N/A N=100 Treatment

Acute Coronary Syndrome KCMC_1

Hypertension · HIV

Bottom Line

View on ClinicalTrials.gov: NCT06503991 ↗

Enrolled (actual)

100

Serious AEs

0.0%

Results posted

Feb 2026

Primary outcome: Primary: Feasibility as Measured by the Number of Total Scheduled Intervention Sessions (CHW Counseling Sessions, Doctor's Visits, Phone Calls) Attended — 589 Scheduled sessions

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Community Health Worker (CHW)-delivered Hypertension Management Pilot (CHAMP) (Behavioral); Control of Blood Pressure and Risk Attenuation (COBRA) (Behavioral)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Duke University
Primary completion: Sep 2025

Outcome Measures

Outcome	Result	p-value
PRIMARY Feasibility as Measured by the Number of Total Scheduled Intervention Sessions (CHW Counseling Sessions, Doctor's Visits, Phone Calls) Attended	589	—
SECONDARY Number of Participants Reporting Adherence to an Anti-hypertensive Medication at 6-month Follow-up	91	—
SECONDARY Number of Participants With Controlled Blood Pressure at 6-month Follow-up	73	—
SECONDARY Hypertension Knowledge-Level Scale (HK-LS) Scores at 6-month Follow-up	20.4	—

Summary

To adapt and assess the implementation and preliminary effectiveness of an integrated COBRA and CHAMP multi-component community health worker-delivered hypertension intervention in improving blood pressure control among PLWH in northern Tanzania.

Eligibility Criteria

Inclusion Criteria

Known HIV
Hypertension with single reading of SBP=>160 mm Hg and /or DBP=>100mm Hg
Two separate measurements of SBP => 140 mmHg and/or DBP=> 90 mmHg

Exclusion Criteria

No documented elevated blood pressure
No HIV infection

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06503991). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.